Form 4 for EW Edwards Lifesciences
Accepted 2025-09-15 00:00:00 ET · period of report 2025-09-13 · accession 0001225208-25-007992 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-15 | 2025-09-13 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | F - Tax | $77.57 | -262 | 7,927 | -3% | -$20.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-13 | F | D | 262 | $77.57 | 7,926.93 | D | — | — |